Cantel Medical Corp (CMD) Return on Investment ROI from the third quarter of 2021 to third quarter of 2020 and for the year 2021, average high and low, overall ranking from Apr 30 2021 to Apr 30 2020 - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Cantel Medical Corp   (NYSE: CMD)


Cantel Medical's ROI from its third quarter of 2021 to the third quarter of 2020 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Cantel Medical's ROI in the third quarter of 2021?
Cantel Medical Corp achieved a return on average invested assets (ROI) of 2.84 % in its third quarter of 2021, which is below Cantel Medical's average return on investment, which stands at 8.14%.

ROI has improved compared to 2.57% in the second quarter of 2021, due to net income growth.

Within the Healthcare sector 181 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the second quarter of 2021 from 1232 to 2025.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Apr 30 2021)
III. Quarter		 (Jan 31 2021)
II. Quarter		 (Oct 31 2020)
I. Quarter		 (Jul 31 2020)
IV. Quarter		 (Apr 30 2020)
III. Quarter
Y / Y Investment Change TTM 22 % 40.06 % 63.15 % 102.65 % 78.24 %
Y / Y Net Income Change TTM 85.19 % 127.94 % 42.33 % -19.36 % 243.93 %
Investment (TTM) in Millions 1,788 1,816 1,840 1,892 1,714
Return On Investment (TTM) 2.84 % 2.57 % 1.82 % 0.78 % 1.87 %
CMD's Overall Ranking # 2025 # 1232 # 1979 # 0 # 1859
Seq. Investment Change TTM 1.02 % 1.81 % 1.68 % 16.67 % 15.98 %
Seq. Net Income Change TTM 11.41 % 44.22 % 136.39 % -51.24 % 37.12 %
Net Income (TTM) in Millions 52 47 32 14 28

CMD Company Profile >> Back to CMD Roi Comparisons >> See Annual CMD Return On Investment



Return On Investment CMD's Ranking
Within: No.
Industry # 56
Sector # 182
Overall # 2025

Return On Investment Statistics
High Average Low
12.51 %
8.14 %
0.77 %
(Jan 31 2018)   (Jul 31 2020)







Financial Statements
Cantel Medical's III. Quarter Investments $ 1,788 Millions CMD's Balance sheet
Cantel Medical's III. Quarter Income $ 21 Millions Quarterly CMD's Income Statement
CMD's Income by Division See CMD's Income by Division


CMD Annual Return On Investment (Jul 31 2020)
2020		 (Jul 31 2019)
2019		 (Jul 31 2018)
2018		 (Jul 31 2017)
2017		 (Jul 31 2016)
2016
Total Investments in Millions 1,892 890 801 680 598
Y / Y Investment Growth 112.69 % 11.03 % 17.91 % 13.61 % 16.69 %
Net Income in Millions 14 55 91 71 60
Y / Y Net Income Growth -75.1 % -39.54 % 27.55 % 19.06 % 25.02 %
Annual Return On Investment 0.72 % 6.19 % 11.36 % 10.5 % 10.02 %


Annual Roi Comment
In the fiscal year 2020 ROI decreased relative to the previous year to 0.72 %, due to deterioration of net income.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
CMD's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for CMD's Competitors
Subscribers only: Roi for Cantel Medical's Suppliers
Subscribers only: Return On Investment for CMD's Customers

Other Ratios
CMD's Roa CMD's Inventory Turnover Ratio CMD's Growth Rates CMD's Dividend Statistics
CMD's Profitability Ratios CMD's Asset Turnover Ratio CMD's Dividend Growth
CMD's Roe CMD's Valuation Ratios CMD's Financial Strength Ratios CMD's Dividend Payout Ratio



Companies with similar Return On Investment at Apr 30 2021, within Healthcare Sector ROI
Charles River Laboratories International inc   7.79 %
Lhc Group Inc   7.75 %
Fonar Corporation  7.70 %
Atea Pharmaceuticals Inc   7.58 %
Steris Plc  7.58 %
Minerva Neurosciences Inc   7.51 %
Hill rom Holdings Inc   7.50 %
Cryo cell International Inc   7.50 %
Tvardi Therapeutics Inc   7.38 %
Msa Safety Inc  7.26 %
Phibro Animal Health Corporation  7.22 %
National Healthcare Corp  7.20 %
Pra Health Sciences Inc   7.09 %
Ufp Technologies Inc   7.07 %
Catalent Inc   6.96 %
Global Cord Blood Corp  6.96 %
Vaso Corporation  6.86 %
Haemonetics Corporation  6.82 %
Vanda Pharmaceuticals Inc   6.82 %
Eagle Pharmaceuticals inc   6.78 %
Encompass Health Corporation  6.77 %
Jrsis Health Care Corp  6.44 %
Select Medical Holdings Corp  6.41 %
Davita Inc   6.39 %
Ensign Group Inc  6.13 %
Hanger inc.  6.09 %
P3 Health Partners Inc   6.07 %
Icu Medical Inc  6.05 %
Baxter International Inc   5.97 %
Carlisle Companies Incorporated  5.93 %

Date modified: 2026-09-08T15:10:18+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.